Brett A Hathaway
Overview
Explore the profile of Brett A Hathaway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hathaway B, Li A, Brodie H, Silveira M, Tremblay M, Seo Y, et al.
Eur J Neurosci
. 2024 Feb;
59(7):1621-1637.
PMID: 38369911
Deficits in cost/benefit decision making is a critical risk factor for gambling disorder. Reward-paired cues may play an important role, as these stimuli can enhance risk preference in rats. Despite...
2.
Hales C, Silveira M, Calderhead L, Mortazavi L, Hathaway B, Winstanley C
Psychopharmacology (Berl)
. 2024 Jan;
241(5):947-962.
PMID: 38172238
Rationale: The rat cognitive effort task (rCET), a rodent model of cognitive rather than physical effort, requires animals to choose between an easy or hard visuospatial discrimination, with a correct...
3.
Mortazavi L, Hynes T, Chernoff C, Ramaiah S, Brodie H, Russell B, et al.
J Neurosci
. 2023 Jan;
43(6):979-992.
PMID: 36623876
Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent...
4.
Brodie H, Hathaway B, Li A, Baglot S, Kaur S, Hill M, et al.
Behav Neurosci
. 2022 Nov;
137(1):41-51.
PMID: 36395021
The main psychoactive compound within the cannabis plant, Δ9-tetrahydrocannabinol (THC), is thought to drive both the sensation of "high" and the cognitive impairments associated with cannabis consumption. Researchers keen to...
5.
Hathaway B, Schumacher J, Hrelja K, Winstanley C
eNeuro
. 2021 Nov;
8(6).
PMID: 34815296
Previous research has indicated that reward-paired cues can enhance disadvantageous risky choice in both humans and rodents. Systemic administration of a serotonin 2C receptor antagonist can attenuate this cue-induced risk...
6.
Hynes T, Hrelja K, Hathaway B, Hounjet C, Chernoff C, Ebsary S, et al.
Addict Biol
. 2021 Feb;
26(6):e13022.
PMID: 33559379
Gambling and substance use disorders are highly comorbid. Both clinical populations are impulsive and exhibit risky decision-making. Drug-associated cues have long been known to facilitate habitual drug-seeking, and the salient...
7.
Silveira M, Wittekindt S, Mortazavi L, Hathaway B, Winstanley C
J Psychopharmacol
. 2020 Jan;
34(4):452-466.
PMID: 31913079
Background: Individuals must frequently evaluate whether it is worth allocating cognitive effort for desired outcomes. Motivational deficits are a common feature of psychiatric illness such as major depression. Selective serotonin...
8.
Langdon A, Hathaway B, Zorowitz S, Harris C, Winstanley C
Psychopharmacology (Berl)
. 2019 Jul;
236(8):2543-2556.
PMID: 31256220
Rationale: Pairing rewarding outcomes with audiovisual cues in simulated gambling games increases risky choice in both humans and rats. However, the cognitive mechanism through which this sensory enhancement biases decision-making...